Most Recent Posts
Our President and CEO John Castellani was published in the New York Times' Letters to the Editor this morning, in response to a
I've been a contributor on our very own blog, the Catalyst, for a year now. I try my best to write interesting blog posts that pertain to the incredible work biopharmaceutical scientists do to help improve patient care in the U.S. and around the world.
This morning, British scientist John Gurdon shared one of two Nobel Prizes awarded this year in physiology and medicine. Dr.
In this month's issue of Psychology Today, there was a good read about the psychological impact of having a rare disease, 'The Loneliest Fight', profiling four patients' experience with very differe
Medicare Today has released its 2012 beneficiary satisfaction survey results today and to put it simply, seniors love Medicare Part D.
Over a decade ago, when SARS (Severe Acute Respiratory Syndrome) was first detected in China, it took significant time to identify the virus and to understand how the disease spread among affected populations.
PhRMA president & CEO John Castellani and Jim Greenwood, president and CEO of the Biotechnology Industry Association (BIO) team-up at Patent Docs to c